Hidradenitis Suppurativa

Overview

Hidradenitis suppurativa (HS) is a chronic, relapsing inflammatory skin disease characterized by painful nodules, abscesses, and sinus tracts in apocrine gland-bearing skin (axillae, groin, inframammary folds). Long classified as a purely dermatological condition, emerging evidence reveals HS as a systemic inflammatory disorder with a significant gut microbiome component — connecting it to the broader gut-skin axis framework.

Microbiome Associations

Gut Microbiome

Mendelian randomization analysis has identified two gut taxa with causal risk effects on HS:

Remarkably, 40% of HS patients harbor a gut microbiota configuration similar to Crohn's disease, characterized by enrichment of pathogenic genera and depletion of beneficial genera including faecalibacterium prausnitzii cronin 2023 diet microbiome crohns hidradenitis. This overlap is consistent with clinical observations that HS and CD frequently co-occur and share TNF-alpha-driven pathology.

Skin Microbiome

The HS lesional skin microbiome shows enrichment of anaerobic and biofilm-forming organisms in sinus tracts, including Prevotella, Porphyromonas, and coagulase-negative staphylococci. The tunneling nature of HS sinus tracts creates anaerobic microenvironments that may select for specific pathobiont communities — paralleling the oxygen-dependent ecological dynamics seen in gut dysbiosis.

Metal Associations

Direct metal studies in HS are limited. However, the strong overlap with Crohn's disease microbiome patterns and shared TNF-alpha-driven inflammation suggest that metal-microbiome dynamics relevant to CD — including iron-siderophore competition and zinc-dependent metalloprotease activity — may operate in HS as well. Nickel allergy, which is highly prevalent in inflammatory skin conditions, has not been systematically studied in HS but represents a plausible connection given nickel's role in immune sensitization.

Associated Conditions

  • crohns disease — 40% gut microbiota overlap; shared TNF-alpha pathology; clinical co-occurrence well-documented. Both conditions respond to anti-TNF therapy (adalimumab is approved for both).

Environmental Factors

  • Diet — Western diet patterns (high-fat, low-fiber) are associated with HS severity, consistent with the gut-microbiome-mediated mechanism
  • Smoking — Strong independent risk factor; may influence both skin and gut microbiome composition
  • Obesity — Mechanical and inflammatory contributor; shared metabolic endotoxemia pathway

Key Studies

Open Questions

  • Does the Lachnospira risk association operate through SCFA-mediated cutaneous immune modulation, or through a different mechanism?
  • Would dietary interventions targeting the gut microbiome (fiber supplementation, Mediterranean diet) improve HS outcomes?
  • Are the shared CD-HS microbiome features a cause or consequence of shared genetic susceptibility at TNF pathway loci?

Cross-References